Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-11-041203
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-27 20:46:50
Reporting Period:
2011-07-27
Filing Date:
2011-07-27
Filing Date Changed:
2011-07-27
Accepted Time:
2011-07-27 21:46:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306194 Iii Z Williamson Bradford 3280 Bayshore Boulevard
Brisbane CA 94005
Svp-Clinical Science No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-07-27 1,800 $8.73 63,377 No 4 M Direct
Common Stock Disposition 2011-07-27 1,800 $35.16 61,577 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-07-27 1,800 $0.00 1,800 $8.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
79,700 2020-06-08 No 4 M Direct
Footnotes
  1. These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
  2. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $35 to $35.54 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  3. 33.3334% of the total number of shares subject to the stock option vest and become exercisable cumulatively on each of the following dates: June 8, 2011, December 8, 2011 and June 8, 2012.